BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37884213)

  • 1. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured cubosomes as advanced drug delivery system.
    Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
    Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyotropic liquid crystals for parenteral drug delivery.
    Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
    J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Crystalline Phases for Enhancement of Oral Bioavailability.
    Zhang X; Wu W
    AAPS PharmSciTech; 2021 Feb; 22(3):81. PubMed ID: 33619612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
    Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
    J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
    Garti N; Libster D; Aserin A
    Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cubic and hexagonal liquid crystals as drug delivery systems.
    Chen Y; Ma P; Gui S
    Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cubic lyotropic liquid crystals as drug delivery carriers: Physicochemical and morphological studies.
    Chountoulesi M; Pippa N; Pispas S; Chrysina ED; Forys A; Trzebicka B; Demetzos C
    Int J Pharm; 2018 Oct; 550(1-2):57-70. PubMed ID: 30121331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyotropic liquid crystal systems in drug delivery.
    Guo C; Wang J; Cao F; Lee RJ; Zhai G
    Drug Discov Today; 2010 Dec; 15(23-24):1032-40. PubMed ID: 20934534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
    Koynova R; Tenchov B
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
    Milak S; Zimmer A
    Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
    Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
    Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.